Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologies

6 Nov 2023

Abstract excerpt

Novel liquid biopsy technologies are creating a watershed moment in cancer early detection. Evidence supporting population screening is nascent, but a rush to market the new tests is prompting cancer early detection researchers to revisit the standard blueprint that the Early Detection Research Network established to evaluate novel screening biomarkers. In this commentary, we review the Early Detection Research...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AI in cancer detection
Share to Cancer Genomics and Diagnostics
Share to Radiomics and Machine Learning in Medical Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37941446
DOI: 10.1093/jnci/djad227

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Revisiting the standard blueprint for biomarker development to address emerging cancer early detection technologiesPMID 37941446Read ↗

The promise of biomarkers in cancer screening and detection.Semantic proximity Read ↗

In Pursuit of Greater Reproducibility and Credibility of Early Clinical Biomarker ResearchSemantic proximity Read ↗

Biomarker-Driven Early Clinical Trials in OncologySemantic proximity Read ↗

Multicancer Early Detection Tests - Keeping a High Bar for Evidence of Benefit.Semantic proximity Read ↗

Statistical and practical considerations for clinical evaluation of predictive biomarkers.Semantic proximity Read ↗

AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosisSemantic proximity Read ↗

Patented Biomarker Panels in Early Detection of CancerSemantic proximity Read ↗

Biomarker-driven patient selection for early clinical trialsSemantic proximity Read ↗

Biomarker Tests Need Closer Scrutiny, IOM ConcludesSemantic proximity Read ↗

The Impact of Multi-Cancer Early Detection Tests on Cancer Mortality: A 10-Year Microsimulation ModelSemantic proximity Read ↗

Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics.Semantic proximity Read ↗

Validation of biomarkers as early predictors of diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.